Appendix C 21-22

Appendix C: EPICORE Centre Publications

Tsuyuki RT, Watson KE. Why pharmacist prescribing needs to be independent. (Editorial). Can Pharm J 2020;153(2):67-69.
Watson KE, Van Haaften D, Horon K, Tsuyuki RT. The evolution of pharmacists’ roles in disasters, from logistics to assessing and prescribing. (Editorial). Can Pharm J 2020;153(3):129-131. DOI: 10.1177/1715163520916921.
Al Hamarneh YN, Rosenberg-Yunger Z, Saxena A, Waite NM, Dolovich L, Tsuyuki RT. Patient-oriented pharmacy practice research: Why should we care? (Commentary). Can Pharm J 2020;153(3):133-136. DOI: 10.1177/1715163520909122.
Carbonneau M, Eboreime EA, Hyde A, Campbell-Scherer D, Faris P, Gramlich L, Tsuyuki RT, Congly SE, Shaheen AA, Sadler M, Zeman M, Spiers J, Abraldes JG, Sugars B, Sia W, Green L, Abdellatif D, Schaefer JP, Selvarajah V, Marr K, Ryan D, Westra Y, Bakshi N, Varghese JC, Tandon P. The cirrhosis care Alberta (CCAB) protocol: implementing an evidence-based best practice order set for the management of liver cirrhosis – a hybrid type I effectiveness-implementtion trial. BMC Health Services Research 2020;20:558. DOI: 10.1186/s12913-020-05427-8. Published on June 18, 2020.
Farrell B, Tsuyuki RT. Pharmacists step up to the challenge of COVID-19. (Editorial). Can Pharm J 2020:153(4);185. doi: 10.1177/1715163520930705.
Tsuyuki RT, Midodzi W, Villa-Roel C, Marciniuk D, Mayers I, Vethanayagam D, Chan MCY, Rowe BH. Diagnostic Practices for Patients with Shortness of Breath and Presumed Obstructive Airways Disorders: a cross-sectional analysis. CMAJ Open 2020;8(3):E605-E612. DOI:10.9778/cmajo.20190168. Published online September 25, 2020.
Campbell NRC, Dattani S, Bell A, Gelfer M, Cloutier L, Petrella R, Lindsay P, Leung AA, McLean D, Kaczorowski J, Tsuyuki RT. Urgent need to increase the rates of diagnosing, treating and controlling hypertension in older women: A call for action. Can Pharm J 2020;153(5):264-269. DOI: 10.1177/1715163520947006. Published August 19, 2020.
Wu Q, Tsuyuki RT, Hall J, Biggs C, Charrois T. Professional abstinence: What does it mean for pharmacy student (and our future…)? (Commentary). Can Pharm J 2020;153(5):240-242. DOI: 10.1177/1715163520945733. Published August 28, 2020.
Tsuyuki RT. Realizing our ultimate opportunity. (Editorial). Can Pharm J 2020;153(5):238-239. DOI: 10.1177/1715163520947007.
Tsuyuki RT, Arora V, Barnes M, Beazely MA, Boivin M, Christofides A, Patel H, Laroche J, Sihota A, So R. Canadian national consensus guidelines for naloxone prescribing by pharmacists. Can Pharm J 2020;153(6):347-351. DOI: 10.1177/1715163520949973. First published August 26, 2020. French translation: Lignes directrices canadiennes de consensus national pour la prescription de naloxone par les pharmaciens. Can Pharm J 2020;153(6):1-5.
So R, Al Hamarneh Y, Barnes M, Beazely MA, Boivin M, Laroche J, Patel H, Sihota A, Smith T, Tsuyuki RT. The status of naloxone in community pharmacies across Canada. Can Pharm J 2020;153(6):352-356. DOI: 10.1177/1715163520958435. First published September 21, 2020.
Schulz M, Griese-Mammen N, Schumacher P, Strauch D, Freudewald L, Said A, Tsjuyuki R, Laufs U, Kintscher U, Böhm M, Mahfoud F. Development and implementation of blood pressure screening and referral guidelines for German community pharmacists. J Clin Hypertens 2020;22:1807-1816.
Campbell NRC, Khalsa T, Ordunez P, Rodriquez Morales YA, Zhang X-H, Parati G, Padwal R, Tsuyuki RT, Cloutier L, Sharman JE. Brief online certification course for measuring blood pressure with an automated blood pressure device. A free new resource to support World Hypertension Day Oct 17, 2020. J Clin Hypertens 2020;22:1754-1756. DOI: 10.1111/jch.14017. Published online September 3, 2020.
Gelfer M, Bell A, Petrella R, Campbell NRC, Cloutier L, Lindsay P, Leung AA, Morris D, McLean D, Tsuyuki RT, Dattani S, Kaczorowski J. Take urgent action diagnosing, treating, and controlling hypertension in older women. (Commentary). Canadian Family Physician 2020;66:726-731.
Campbell DJT, Saunders-Smith T, Manns BJ, Tonelli M, Ivers N, Hemmelgarn BR. Tsuyuki RT, Pannu R, King-Shier K. Exploring patient and pharmacist perspectives on complex interventions for cardiovascular prevention: A qualitative descriptive process evaluation. Health Expect.2020;00:1–17.
Garcia-Cardenas V, Verner Rossing C, Fernandez-Llimos F, Schulz M, Tsuyuki R, Bugnon O, Stumpf Tonin F, Benrimoj SI. Pharmacy practice research – A call to action. Research in Social and Administrative Pharmacy 2020;16(11):1602-1608.
Necyk CM, Johnson JA, Minhas-Sidhu J, Tsuyuki RT, Eurich D. Evaluation of Comprehensive Annual Care Plans by Pharmacists in Alberta for Patients with Complex Conditions. J Am Pharm Assoc 2020;60:1029-1036. Published online 19 September 2020.
Tsuyuki RT, Watson KE. COVID-19 testing by pharmacists. (Editorial). Can Pharm J 2020;153(6):314-315. DOI: 10.1177/1715163520961981. First published October 7, 2020.
Fletcher JM, Saunders-Smith T, Manns BJ, Tsuyuki R, Hemmelgarn BR, Tonelli M, Campbell DJT. Pharmacist and patient perspectives on recruitment strategies for randomized controlled trials: A qualitative analysis. BMC Medical Research Methodology 2020;20:270. Published online 31 October 2020.
Truong MB. Ngo E, Ariansen H, Tsuyuki RT, Nordeng H. The effect of a pharmacist consultation on pregnant women’s quality of life with special focus on nausea and vomiting: an intervention study. BMC Pregnancy and Childbirth 2020;20:766. Published online 09 December 2020.
Pohlman K, Carroll L, Tsuyuki RT, Hartling L, Vohra S. Comparison of active versus passive surveillance adverse event reporting in a pediatric ambulatory chiropractic care setting: a cluster randomized controlled trial. BMJ Open Quality 2020;9:e000972. doi:10.1136/ bmjoq-2020-000972. First published online November 17, 2020.
Tsuyuki RT, Pimlott N. Risks of maternal codeine intake in breastfed infants: A Joint Statement of Retraction from the Canadian Pharmacists Journal and Canadian Family Physician. (Commentary). Can Pharm J 2021;154(1):7-8. DOI: 10.1177/1715163520970443. First published November 18, 2020.
Tsuyuki RT. Proactive practice. (Editorial). Can Pharm J 2021;154(1)6. DOI: 10.1177/1715163520977274. First published December 14, 2020.
Watson KE, Al Hamarneh YN, Rabi D, Daskalopoulou SS, Tsuyuki RT. Hypertension Canada’s 2020 hypertension guidelines for pharmacists: An update. Can Pharm J 2021;154(1):19-25. DOI: 10.1177/1715163520975809. First published December 10, 2020.
Watson KE, Tsuyuki RT. Pharmacists must combat mis/disinformation! (Editorial). Can Pharm J 2021;154(2):68-69. DOI: 10.1177/1715163521992037. First published February 17, 2021.
Al Hamarneh YN, Marra C, Gniadecki R, Keeling S, Morgan A, Tsuyuki R. RxIALTA: evaluating the effect of a pharmacist-led intervention on CV risk in patients with chronic inflammatory diseases in a community pharmacy setting: a prospective pre–post intervention study. BMJ Open 2021;11:e043612. doi:10.1136/bmjopen-2020-043612. First published March 24, 2021.
Le Melledo, J-M, Baker G, Gyenes G, Tsuyuki R, Jurasz P. L-Arginine and NOS activity, a complex relationship. (Letter to Editor). Psychopharmacology 2021;238:1223-1224.
Campbell NRC, Ordunez P, Giraldo G, Rodrigues Morales YA, Lombardi, C, Padwal R, Tsuyuki RT. WHO HEARTS, a global program to reduce cardiovascular disease burden: Experience implementing in the America’s and opportunities in Canada. Can J Cardiol 2021;37:744-755. Published online December 10, 2020. doi:
Al Hamarneh YN, Okada H, Tsuyui RT. Real-world implementation of diabetes management by pharmacists: The RxING Practice Tool. Can Pharm J 2021;154(3):160-165. DOI: 10.1177/17151635211004964. First published April 23, 2021.
Leung AA, Bell A, Tsuyuki RT, Campbell NRC. Refocusing on hypertension control in Canada. (Commentary). CMAJ 2021;193:E854-5. Doi: 10.1503/cmaj.210140.
Grindrod K, Waite N, Constantinescu C, Watson KE, Tsuyuki R. COVID-19 vaccine hesitancy: Pharmacists must be proactive and move the middle. (Editorial). Can Pharm J 2021;154(3):133-135. DOI: 10.1177/17151635211005763. First published April 19, 2021.
Watson KE, Tsuyuki RT, Beahm N, Sedore R, Bell A. Assessment of the educational competencies for the Hypertension Canada Professional Certification Program (HC-PCP) designed for implementation of hypertension guidelines into primary care. Can Pharm J 2021;154(x):xx-xx. DOI: 10.1177/17151635211016493.
Santarossa TM, So R, Smyth P, Gustavsen S, Tsuyuki RT. Medical Cannabis Use in Canadians With Multiple Sclerosis. Online ahead of print. DOI: 
Lee DH, Watson KE, Al Hamarneh YN. Impact of COVID-19 on frontline pharmacists’ roles and services in Canada: The INSPIRE Survey. Canadian Pharmacists Journal. 2021; 154:368-373
Rahemtulla KA, Cheema MK, Nickonchuk T, Guirguis M, Al Hamarneh YN, Damji. Quantifying the cost of single-use minims and multidose bottles for eye drops in routine ophthalmic practice: a multicentre study. Canadian Journal of Ophthalmology. In Press. Published online July 17, 2021.
So R, Oleksyn C, Al Hamarneh YN, Tsuyuki RT. “Pharmacist First” Innovative Workflow Plan in Patients with Hypertension and/or Diabetes. Canadian Pharmacists Journal. 2021:154 (6): 376-380. DOI: 10.1177/17151635211016498 
Al Hamarneh YN, Marra Carlo, Gniadecki R, Keeling S, Morgan A, Tsuyuki, R. RxIALTA: Evaluating the Effect of a Pharmacist-Led Intervention on CV Risk in Patients with Chronic Inflammatory Diseases in a Community Pharmacy Setting. A Prospective Pre-Post-Intervention Study. BMJ Open 2021;11:e043612. doi:10.1136/bmjopen-2020-043612. First published March 24, 2021.
Al Hamarneh YN, Okada H, Tsuyuki RT. Real world implementation of diabetes management by pharmacists: The RXING Practice Tool. Can Pharm J 2021;154(3):160-165. DOI: 10.1177/17151635211004964. First published April 23, 2021.
Henry T, Qazi S, Kutanzi E, Damji KF, Whitford R, Al Hamarneh YN. A step toward enhancing medical professionals’ and students’ empathy for visually impaired patients using virtual reality. Canadian Journal of Ophthalmology. 2021; 56 (5), 338-339.
Henry T, Palakkamanil M, Al Hamarneh YN, Tennant MTS. An evaluation of Alberta retina health service delivery in an office setting: a crosssectional survey of patient experience. BMC Health Services Research;2020: 20 (1), 1-9. Published on December 4, 2020.
Zolezzi M, Elhakim A, Hejazi T, Kattan L, Mustafa D, Aboelbaha S, Homs S, Al Hamarneh YN. Evaluation of a Mobile Application Tool to Assist Health Care Providers in Cardiovascular Risk Assessment and Management. Journal of Emergency Medicine, Trauma and Acute Care. 2022; 2022:71. 
Burnham RS, Pan B, Al Hamarneh YN, Amatto A, Smith AD. An Assessment of the Minimal Clinically Important Difference for the Pain Disability Quality-Of-Life Questionnaire-Spine. Interventional Pain Medicine. 2022 Jan 1;1:100016.
Thai J, Peschken C, Pan B, Al Hamarneh YN, Keeling S. “Evaluation of Comorbidities and Damage in Canadian Patients With Systemic Lupus Erythematosus”. Lupus Science & Medicine, 2021;8(Suppl 2):A1–A75.
Thai J, Peschken C, Bo Pan, Al Hamarneh YN, Reynolds J, Avina-Zubieta A, Ann Clarke, Hitchon C, Tisseverasinghe A, Fortin P, Ivory C, Haaland D, Legault K, Matsos M, Pope J, Stephanie Keeling. “Evaluation of Comorbidities and Damage in Canadian Patients With Systemic Lupus Erythematosus”. Journal of Rheumatology, 2021; 48 (7), 1145-1146
 S Goswami, M Rosenthal, S Nair, S Inguva, YN Al Hamarneh, R Tsuyuki. “Applying the Stages of Implementation Completion (SIC) Framework Retrospectively to a Community Pharmacy Clinical Intervention Implementation Project for Scaling up Future Success”. Value in Health, 2021; 24, S82
Tsuyuki RT, Al Hamarneh YN, Chan JCH, Dobie J, Santarossa TM, So R, Wu Q, Watson KE. “Pharmacy, we have an image problem . . . (and here’s a solution)”, Canadian Pharmacists Journal, 2021; 154: 353-354.
Tsuyuki RT, Pimlott N. Risks of maternal codeine intake in breast-fed infants: A Joint Statement of Retraction from the Canadian Pharmacists Journal and Canadian Family Physician. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 2021;154(1):7-8. doi:10.1177/1715163520970443

Tougas SR, Lodha N, Vandermeer B, et al. Prevalence of Detection of Clostridioides difficile Among Asymptomatic Children: A Systematic Review and Meta-analysis. JAMA Pediatr. 2021;175(10):e212328. doi:10.1001/jamapediatrics.2021.2328
Pillay J, Donovan L, Guitard S, et al. Screening for Gestational Diabetes: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021;326(6):539-562. doi:10.1001/jama.2021.10404
Wingert A, Pillay J, Moore DL, et al. Burden of illness in infants and young children hospitalized for respiratory syncytial virus: A rapid review. Can Commun Dis Rep. 2021;47(9):381-396. Published 2021 Sep 10. doi:10.14745/ccdr.v47i09a05
AlBalawi MM, Castro-Codesal M, Featherstone R, et al. Outcomes of Long-Term Noninvasive Ventilation Use in Children with Neuromuscular Disease: Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2022;19(1):109-119. doi:10.1513/AnnalsATS.202009-1089OC